Pfizer Sells Capsugel: Will More Asset Sales Follow?
Supreme Court Limits Lawsuits Against Vaccine Makers
Before the High Court: Can Drug Companies Be Sued Over Vaccine Designs?
Pfizer Buys King Pharma for $3.6 Billion
Pfizer Earnings Rise 9%, Topping Estimates
Teva Cleared to Sell Generic Effexor XR -- a Pfizer Blockbuster
Inside Wall Street: Pfizer's Pipeline Looks Primed to Deliver
Pfizer Plans 6,000 More Manufacturing Job Cuts Globally
Ready to rumble: Pfizer's generic biotech drug push could pit it against Amgen
Pfizer in court again, this time for Wyeth's menopause treatment Prempro
Pfizer earnings beat the Street. Beating future hurdles will be tougher
J&J, Abbott beat expectations: a good sign for pharma results yet to come?
Snapple may have to pay up for claiming iced tea is 'all natural'
Pfizer tops estimates, but challenges remain
Despite pharma deals, M&A is still scarce
Supreme Court: Federal law might not shield companies from state lawsuits